Acute Otitis Media: Classification, Etiology, Diagnosis and Treatment
Acute otitis media is a group of middle ear inflammation with pain and hearing loss. Etiology, symptoms, diagnosis and treatment of acute otitis media.
Chronic middle ear diseases are a group of long-term or recurrent pathological conditions that affect the structures of the middle ear (tympanic cavity, tympanic membrane, auditory ossicles). They are characterized by persistent inflammation, fluid (exudate), structural changes in the mucous membrane and bone elements, which often leads to progressive hearing loss.
Chronic middle ear diseases include:
The causes of this condition are similar to those of acute exudative otitis media (see Ref. «
Acute Otitis Media: Classification, Etiology, Diagnosis and Treatment»
).
The underlying cause of this condition is obstruction of the auditory tube orifice in the nasopharynx, which can be either inflammatory or allergic in nature.
Without adequate treatment of acute exudative otitis media, especially with recurrent upper respiratory tract infections, the pathologic process in the ear becomes chronic.
On the background of the already existing exudate in the middle ear cavities, further transformations take place. During 12-24 months, the exudate becomes saturated with a protein component and becomes thicker and more viscous, turning into a mucosal content.
After 24 months the processes in the mucous membrane undergo reverse development, there is degeneration of serous glands and a decrease in the number of bocaloid cells. The fluid component is not formed in such quantity and mucociliary transport is restored. In some cases, without adequate treatment, the mucosal content further organizes into fibrous strands, which subsequently leads to adhesive processes in the middle ear cavity.
It is characterized by progressive hearing loss up to deafness, noise and congestion in the ear on the affected side.
Patients are examined according to the same scheme as in acute exudative otitis media:
As with acute exudative otitis media, it is initially necessary to treat the cause that caused the process. Due to the fact that the content in the ear cavity is characterized by increased viscosity and prolonged stay, if there is no effect from conservative therapy, surgical treatment is recommended.
The purpose of surgical intervention is evacuation of exudate and aeration of the middle ear cavity. Paracentesis with aspiration of pathologic contents is performed. In some cases, a drainage tube (shunt) is inserted to maintain constant pressure and aeration of the tympanic cavity.
This pathology is an outcome of sluggish chronic exudative otitis media and recurrent acute otitis media.
Adhesive otitis media is also characterized by auditory tube dysfunction. Persons with year-round allergic rhinitis and poorly developed mastoid cells are most susceptible.
The process develops against a background of constant inflammation with the presence of exudate in the tympanic cavity. The pathological content over time undergoes a number of changes, is organized, fibrin falls out in the form of adhesions, which then becomes more dense and sclerosed.
Scar tracts are formed that fix middle ear structures, especially the middle ear, to each other:
The tympanic membrane is retracted so severely in some areas that retraction pockets form, which may be the source of retraction cholesteatoma formation.
As a result, the mobility of the sound-conducting circuit is reduced, leading to conductive hearing loss.
Patients notice a pronounced hearing loss that increases over time. Noise and crackling in the affected ear may be bothersome.
Treatment consists of restoring eardrum mobility, reducing the amount of scar tissue, and restoring the function of the auditory tube.
In initial cases, pneumatic massage of the tympanic membrane and blowing of the auditory tubes are performed. Proteolytic enzymes, glucocorticosteroids are administered intratympanally. Sanation of the nasopharynx and adenotomy are performed.
In case of severe disorders or no effect from conservative therapy, surgical treatment is performed. Scars are excised, mobility of the auditory ossicles is restored. In advanced cases, tympanoplasty with prosthesis of the auditory ossicles is performed.
If the auditory tube function is impaired, a shunt is placed in the tympanic membrane to prevent recurrence.
The etiology of otosclerosis is unknown. The disease is more common in women 30-40 years old and may manifest with hormonal changes such as pregnancy or menopause. It has a genetic predisposition. Otosclerosis is thought to be associated with autoimmune processes as well as with measles virus.
The disease is associated with a disturbance in the organization of the bone tissue of the ear. The process is more often bilateral, and may manifest itself unevenly with predominant changes on one side.
Foci of otosclerosis may occur in the bony labyrinth or around the stapes. The healthy bone tissue of the cochlea undergoes resorption and is replaced by new spongiosa tissue, soft and saturated with many vessels, which is subsequently sclerosed.
When the process spreads to the foot of the stapes, bone tissue grows pathologically around the base of the stapes, anchoring it to the oval window of the cochlea. Ankylosis of the stapes impairs sound conduction, resulting in conductive hearing loss.
The formation of foci of otosclerosis in the labyrinth ladder region causes sensorineural hearing loss.
Hearing loss, noise and ear stuffiness are observed. Patients note slurred speech, which, however, improves in noisy rooms. Complaints increase over time as the disease progresses.
Surgical treatment – stapedectomy – is used to restore hearing. The aim of this treatment method is to remove foci of otosclerosis and the affected stapes and replace it with a titanium prosthesis.
Tympanosclerosis develops against the background of chronic purulent or exudative otitis media, as well as after acute otitis media. Genetic predisposition to the development of tympanosclerosis has been proved.
Sclerotic processes develop as an outcome of a prolonged inflammatory process in the tympanic cavity. As a result of degenerative and fibroplastic changes in the tympanic membrane and mucoperiosteum, tympanesclerotic (TSC) foci located in the deep layers of the mucosa appear.
It is important to note that the mucoperiosteum (middle ear mucosa), in addition to the bony walls of the tympanic cavity, also lining the auditory ossicles.
Histologically, TSC formations are scar tissue with foci of hyaline degeneration and deposits of phosphorus-calcium salts. Visually they are white dense “wax-like drops” with a clear border in the mucosa thickness.
TSC foci restrict the mobility of the tympanic membrane and the chain of auditory ossicles, impairing sound conduction.
The favorite localization of TSC deposits is narrow and blindly closed places where aeration is reduced. Such places are represented in the attic, in the area of the malleus-anvil joint, around the window of the vestibule.
The leading complaint of the patient is hearing loss. In addition, there may be complaints consistent with the underlying disease (purulence, murmurs and ear pain).
In this pathology, only surgical treatment is applicable. Patients undergo sanation of the tympanic cavity with tympanoplasty and ossiculoplasty. An important point is the complete removal of TSC foci to prevent recurrences.
1. What is otosclerosis and its symptoms?
2. What are the causes of otosclerosis?
3. How to treat otosclerosis?
4. What is tympanosclerosis and its symptoms?
5. How to treat tympanosclerosis?
6. How to diagnose exudative otitis media?
7. What are the symptoms of exudative otitis media?
8. How to treat exudative otitis media?
9. What are the clinical guidelines for the treatment of adhesive otitis media?
List of Sources
1.
VOKA Catalog.
https://catalog.voka.io/2.
Total Otolaryngology—Head and Neck Surgery, Anthony P. Sclafani, Robin A. Dyleski, Michael J. Pitman, Stimson P. Schantz. Thieme Medical Publishers, Inc., 2015. ISBN 978-1-60406-646-3.
3.
Бербом Х. Болезни уха, горла и носа / Ханс Бербом, Оливер Кашке, Тадеус Навка, Эндрю Свифт; пер. с англ. – 2-е изд. – М. : МЕДпреcс-информ, 2016. – 776 с. : ил. ISBN 978-5-00030- 322-1.
4.
Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, Hoelting D, Hunter LL, Kummer AW, Payne SC, Poe DS, Veling M, Vila PM, Walsh SA, Corrigan MD. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngol Head Neck Surg. 2016 Feb;154(1 Suppl):S1-S41. doi: 10.1177/0194599815623467. PMID: 26832942.
5.
Yoshida S, Seki S, Sugiyama T, Kikuchi S, Iino Y. Clinical characteristics of atelectatic eardrums and adhesive otitis media in children. Int J Pediatr Otorhinolaryngol. 2022 Aug;159:111188. doi: 10.1016/j.ijporl.2022.111188. Epub 2022 May 26. PMID: 35653949.
6.
Zafar N, Hohman MH, Khan MAB. Otosclerosis. 2024 Mar 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32809506.
7.
Gurr A, Hildmann H, Stark T, Dazert S. Die Therapie der Tympanosklerose [Treatment of tympanosclerosis]. HNO. 2008 Jun;56(6):651-7; quiz 658. German. doi: 10.1007/s00106-008-1749-3. PMID: 18483716.
Link successfully copied to clipboard